HIV+ Issue 12: Table of Contents

	CONTENTS
www.hivplusmag.com MICHAEL W. ELKINS Editor in Chief BOB ADAMS Senior Editor SUE ROCHMAN Editor at Large ROB CHIN Editorial Assistant GARY R. COHAN, MD CADE FIELDS-GARDNER PHILL WILSON Columnists DESIGN AND PHOTOGRAPHY CRAIG EDWARDS Creative Director MICHAEL MATSON Photography Director DENISE BAKER Art Director CHRISTINE LaPORTE Photo Editor EDITORIAL PRODUCTION TRUDY RING Copy Chief BRYAN BUSS, MIKE GRIPPI, LISA WEXTON Copy Editors CONTRIBUTING WRITERS ROBERT DIGIACOMO, CINDRA FEUER, DAVID GILDEN, TODD SAVAGE, BRUCE WRIGHT CONTRIBUTING PHOTOGRAPHERS and ARTISTS ISABELLE CARDINAL, CAROL FRIEDMAN, RICHARD RENALDI, MICHELE A.H. SMITH, JANET VAN HAM EDITORIAL OFFICE 6922 Hollywood Boulevard, Suite 1000 Los Angeles, California 90028-6148 (323) 871-1225; fax (323) 467-6805 e-mail: letters@hivplusmang.com JOE LANDRY Publisher JOE VALENTINO Advertising Director MICHAEL METZGER Production Director TAMMY STONER Advertising Production Manager ADVERTISING OFFICE 80 Eighth Avenue, Suite 315 New York, NY 10011-5126 (212) 334-9119; fax (212) 334-9227 E-mail ads@hivplusmang.com LIBERATION PUTLICATIONS INC. JAMES FRANKLIN President CHARLES R. OSER, JUDY WIEDER Senior Vice Presidents GREG CONSTANTE, CHRISTIN DENNIS, MICHAEL W. ELKINS, JOE LANDRY, BILL MISENHIMER Vice Presidents JUDY WIEDER Corporate Editorial Director	December/January 20001 \| Volume 5, Number 1 Features A Quick Fix? Sure, everyone would like a break from their side-effect-laden anti-HIV regimens. But are structured treatment interruptions the panacea a small number of preliminary clinical studies and the mainstream media have made them out to be? The honest answer is that nobody really knows for sure yet—but probably not. The longer-term evidence is mounting, though, to show that STIs might work for a group of lucky people. And a new option is being explored for others. A Medical Mystery The history of HIV disease has been one filled with uncommon and unusual ailments. Now a new complication has been added to the mix: the bone disease osteonecrosis. Why is this disabling ailment that is usually seen in people taking long-term corticosteroid therapy starting to crop up among HIV patients? Researchers do not know at this point, but they give HIV Plus a laundry list of possibilities that could be contributing factors. Are you at risk? The Secret of His Success Los Angeles physician Wilbert C. Jordan finds that a key to getting members of at-risk populations to be tested and treated for HIV is to offer incentives to his current patients to bring in friends who may need medical attention. The approach has proved so successful that pharmaceutical giant Glaxo Wellcome is using it as a model for Living4Life, a series of similar clinic programs to be established around the country. Africa in Action HIV medications could slash mother-to-child transmission rates in South Africa, but government officials continue to turn a blind eye toward helping poor women get the drugs they need to save their babies? lives. Mercy Makhalamele and her fellow activists—banded together as the Treatment Action Campaign—are trying to force the issue by suing the government for violating national constitutional guarantees of universal health care coverage and even by illegally importing cheap, generic antiretrovirals. Columns plusEditor's Letter The mainstream media do a swell job of glorifying the results from preliminary studies on HIV, but they rarely follow up when the real conclusions can be drawn. So beware of what newspaper or magazine you take your medical advice from. plusClinic Worried about the long-term health implications of those weekly testosterone injections? Gary Cohan extols the virtues of shunning shots in favor of using new transdermal gels and patches for testosterone replacement therapy. plusNutrition Cade Fields-Gardner explains how you can fight off three common side effects of HIV drugs by making simple adjustments to what and how you eat. plusPerspective How can white America best support Africa?s battle against AIDS? Phill Wilson says the most logical place to start is by working and partnering with the African-Americans you see here at home every day. Departments plusLetters Our readers get their turn to sound off about HIV Plus. plusNews Donna Shalala Urges Workplaces to Respond to HIV; A Solar-Powered Device Kills HIV in Breast Milk; President Clinton Signs Reauthorization of the Ryan White Act; Canada Bans Entry for HIV-positive Immigrants; A Judge Places New York City?s AIDS Services Under Federal Control; A California Law Requires HMOs to Refer HIV Patients to Specialists; and more. plusGuide Our updated coverage of federal guidelines on when and how to treat HIV infection; descriptions of anti-HIV drugs as well as HIV-related illnesses and what to do about them; and contact listings of resources for further research.	HIV Plus (ISSN 1522-3086) is published bimonthly by Liberation Publications Inc., 6922 Hollywood Blvd., Suite 1000, Los Angeles, CA 90028-6148. Entire contents © 2000-2001 by Liberation Publications Inc. All rights reserved. Printed in USA. HOW TO CONTACT US SUBSCRIPTION SERVICES To order free copies of HIV Plus in bulk for AIDS service organizations, HIV community groups, or physicians' offices, call (212) 242-4040, Ext. 19, between 9 a.m. and 6 p.m. Eastern time. Written requests should be made on organizational letterhead stating the number of copies you wish to receive. Mail to Circulation Assistant, HIV Plus, 80 Eighth Avenue, Suite 305, New York, NY 10011-5126, or fax your request to (212) 242-1344. CAN'T FIND HIV Plus? If you like the copy of HIV Plus you are now reading but cannot find it at your physician's office or loacl AIDS service organization, give them the above subscription information and let them know that they can subscribe free of charge. LETTERS TO THE EDITOR We welcome letters to the editor. Each must be signed and contain a phone number and address for contact verification. Letters can be published with the author's name withheld; however, all information must be provided for verification purposes. E-mail general correspondence and letters to the editor to letters@hivplusmag.com or mail them to Letters to the Editor, HIV Plus, 6922 Hollywood Blvd., Suite 1000, Los Angeles, CA 90028-6148 or fax them to (323) 467-6805. EDITORIAL POLICY Return postage must accompany all unsolicited manuscripts, drawings, and photographs if they are to be returned; no responsibility can be assumed by HIV Plus for unsolicited manuscripts, drawings, or photographs. All rights in letters, manuscripts, drawings, or photographs sent to HIV Plus will be treated as unconditionally assigned for publication and copyright purposes and are subject to the staff's right to edit and comment editorially. REPRINT PERMISSIONS To make requests to reprint articles from HIV Plus, contact us by fax at (323) 467-6805 or by E-mail at mail@hivplusmag.com with the author's name and information on the article's title, cover date, and page numbers for the issue in which it appeared. Also provide detailed background information about the publication in which you wish to reprint, the context in which you wish to use the article, and when it is expected to be published. BACK ISSUES To order free back issues of HIV Plus in bulk for conferences, meetings, etc., call (212) 242-4040, Ext. 19. To order free individual back issues of HIV Plus, call (323) 871-1225, Ext. 3096.